Molecular Mechanisms in the Pathogenesis of Idiopathic Nephrotic Syndrome
This comprehensive book reviews our current state of knowledge about the pathogenesis of idiopathic nephrotic syndrome (INS), which comprises a heterogeneous group of diseases with distinct histological characteristics, such as minimal-change nephrotic syndrome (MCNS), focal segmental glomeruloscler...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Tokyo :
Springer Japan : Imprint: Springer,
2016.
|
Έκδοση: | 1st ed. 2016. |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Part 1. Introduction
- 1. History of Research on Pathogenesis of Idiopathic Nephrotic Syndrome
- Part 2. Minimal-change nephrotic syndrome (MCNS)
- 2. Hemopexin in Minimal Change Nephrotic Syndrome
- 3. Angiopoietin-like-4 (Angptl4) in MCNS
- 4. Co-stimulatory molecule CD80 (B7.1) in MCNS
- 5. Energy and Mammalian target of rapamycin complex 1 (mTORC1) in minimal change nephrotic syndrome
- 6. The role of c-mip in the pathogenesis of Minimal Change Nephrotic Syndrome
- 7. REGULATORY T-CELLS AND OXIDATIVE STRESS IN MINIMAL CHANGE NEPHROPATHY
- 8. CYTOKINES AS ACTIVE FACTORS IN MINIMAL CHANGE NEPHROTIC SYNDROME
- Part 3. Focal segmental glomerulosclerosis (FSGS)
- 9. Soluble urokinase-type plasminogen activator receptor (suPAR) in Focal Segmental Glomerulosclerosis
- 10. CYTOKINES AS ACTIVE FACTORS IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS
- Part 4. Idiopathic Membranous Nephropathy (IMN)
- 11. M-Type Phospholipase A2 Receptor (PLA2R) and Thrombospondin Type-1 Domain-Containing 7A (THSD7A) in Membranous Nephropathy
- 12. Cationic Bovine Serum Albumin as Cause of Membranous Nephropathy: From Mice to Men
- Part 5. Treatment in Idiopathic Nephrotic Syndrome
- 13. Podocytes as a direct target of drugs used in Idiopathic Nephrotic Syndrome.